SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-064530
Filing Date
2023-11-16
Accepted
2023-11-16 16:30:11
Documents
13
Period of Report
2023-11-15
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K cmra-20231115.htm   iXBRL 8-K 71299
  Complete submission text file 0000950170-23-064530.txt   238057

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cmra-20231115_lab.xml EX-101.LAB 23700
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cmra-20231115_def.xml EX-101.DEF 14681
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cmra-20231115_pre.xml EX-101.PRE 14886
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cmra-20231115.xsd EX-101.SCH 3387
7 EXTRACTED XBRL INSTANCE DOCUMENT cmra-20231115_htm.xml XML 6429
Mailing Address 12 GILL STREET SUITE 4650 WOBURN MA 01801
Business Address 12 GILL STREET SUITE 4650 WOBURN MA 01801 (617)871-2101
Comera Life Sciences Holdings, Inc. (Filer) CIK: 0001907685 (see all company filings)

IRS No.: 874706968 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41403 | Film No.: 231415001
SIC: 2834 Pharmaceutical Preparations